Alembic Pharmaceuticals’ arm recalls 82,400 bottles of Tobramycin Ophthalmic Solution in US

21 Aug 2023 Evaluate

Alembic Pharmaceuticals’ US-based subsidiary is recalling 82,400 bottles of Tobramycin Ophthalmic Solution in the American market. Tobramycin Ophthalmic Solution is used to treat bacterial infections of the eye.

New Jersey-based Alembic Pharmaceuticals Inc is recalling the affected lot (0.3 per cent, 5ml bottle) due to ‘Failed Impurities/Degradation Specifications’. The company initiated the Class III voluntary recall on July 27 this year. As per USFDA, a Class III recall is initiated in a ‘situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences’.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

758.80 -8.35 (-1.09%)
20-Feb-2026 11:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.70
Dr. Reddys Lab 1286.35
Cipla 1336.60
Zydus Lifesciences 899.50
Lupin 2227.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×